[The 2-bromo-alpha-ergocryptine test in patients with amenorrhea and galactorrhea].
Two cases with expanding pituitary tumours following treatment with 2-bromo-alpha-ergocryptine are presented. The lack of normal response to the usual therapeutic dose of the drug suggests the presence of an organic hypothalamo-pituitary disorder that might favour the expansion of a pituitary tumour.
D000328:Adult; D000568:Amenorrhea / Q000175:diagnosis* / Q000209:etiology; D001971:Bromocriptine; D005260:Female; D005687:Galactorrhea / Q000175:diagnosis* / Q000209:etiology; D006801:Humans; D007775:Lactation Disorders / Q000175:diagnosis*; D010911:Pituitary Neoplasms / Q000150:complications* / Q000175:diagnosis; D011247:Pregnancy
D001971:Bromocriptine
2-Brom-alfa-ergokriptin--test u bolesnica s amenorejom i galaktorejom.